📊 #GFR 60 mL/min/1.73 m² remains a clinically meaningful threshold.
In this new study, measured GFR of 60 was associated with higher risks of mortality & kidney failure. Combined creatinine-cystatin C eGFR best matched measured GFR outcomes.
@AfricanAFRAN@ISNkidneycare@gokdigo
Cefepime and Encephalopathy.
This phenomenon is known as Cefepime-Induced Neurotoxicity (CIN) or Cefepime-Induced Encephalopathy (CIE).
The patient presents with these symptoms because of cefepime's structural similarity to GABA (gamma-aminobutyric acid).
The shared pathways between the antibiotic and metabolic encephalopathies (hepatic or uremic) include several key factors:
1. Mechanism of Action:
GABA AntagonismGABA is the brain's primary inhibitory neurotransmitter.Cefepime penetrates the blood-brain barrier, where it acts as a competitive antagonist at GABA_A receptors.
By blocking these inhibitory receptors, cefepime causes neuronal hyperexcitation, manifesting as encephalopathy, delirium, and involuntary muscle jerking (myoclonus).
2. Why it mimics Hepatic or Uremic EncephalopathySimilar Neurotransmitters:
Hepatic and uremic encephalopathies also involve disruptions in inhibitory/excitatory neurotransmission.
The clinical picture of altered mental status and myoclonus is virtually indistinguishable.
Triphasic Waves:
Both conditions frequently present with diffuse slowing and triphasic waves on an EEG.
3. Risk Factors
Renal Impairment:
Cefepime is approximately 85% renally cleared. If the patient has chronic kidney disease (CKD), acute kidney injury (AKI), or if the drug was not appropriately renally dose-adjusted, the cefepime accumulates in the blood and crosses into the CSF at toxic levels.
Blood-Brain Barrier Breakdown:
Systemic inflammation, sepsis, or critical illness (often the reason a patient is on cefepime in the first place) disrupts the blood-brain barrier, allowing greater CNS penetration of the drug.
Underlying Conditions:
Pre-existing central nervous system (CNS) diseases, older age, and hepatic impairment also increase a patient's baseline risk.
●Cefepime-Induced Neurotoxicity is highly reversible once the medication is stopped, typically improving within 24 to 72 hours.
https://t.co/nwlm5CX5YP
🫀📊 **Diastolic dysfunction: are we finally making it simpler?**
Assessing left ventricular diastolic function remains one of the most challenging areas in echocardiography. Multiple variables, load dependence, age-related changes, and often discordant findings make interpretation difficult even for experienced imagers.
A new review proposes a **simplified, tier-based approach** aligned with the 2025 ASE recommendations, aiming to improve the clinical applicability of diastolic function assessment.
🔑 **Key concepts**
✅ Diastolic dysfunction should not be viewed as a single measurement but as a combination of:
• Impaired LV relaxation
• Increased myocardial stiffness
• Elevated filling pressures.
📈 The 2025 approach starts with what may be the most clinically useful marker:
👉 **e′ velocity**, reflecting myocardial relaxation.
Additional markers such as:
• E/e′ ratio
• Left atrial size and function
• Left ventricular hypertrophy
• Left atrial reservoir strain (LARS)
are then integrated in a stepwise fashion.
💡 One of the major advances is the introduction of a **tiered framework** for estimating filling pressures, reducing the number of "indeterminate" studies that frequently complicated the 2016 algorithm.
🏃 In patients with unexplained exertional dyspnoea, the paper reinforces the value of **diastolic stress echocardiography**, recognising that elevated filling pressures often become apparent only during exercise.
🤖 Perhaps the most exciting perspective is the role of artificial intelligence.
The authors propose that diastolic dysfunction may be better understood as a **latent phenotype**, integrating dozens of clinical and imaging variables rather than relying on a few Doppler measurements alone.
Machine-learning models have already demonstrated:
✅ Improved estimation of filling pressures
✅ Better prognostic stratification
✅ Identification of high-risk phenogroups that traditional algorithms may miss.
🎯 **Take-home message**
Diastolic dysfunction is not a binary diagnosis.
A patient admitted for anemia developed new ECG changes after receiving injections intended to correct the anemia.
What is the most likely cause of the anemia?
Type your diagnosis before checking the comments. 👇
A man in his 60s presented with complaints are cough with sputum, cold, body ache for 3 days.
No fever, or difficulty in breathing.
What can be seen here?
Cerebral autoregulation is the local mechanism that keeps cerebral blood flow (CBF) stable despite variations in mean arterial pressure (MAP).
*Autoregulation allows end organs, such as the brain, to maintain consistent blood flow despite fluctuations in perfusion pressure.
*This mechanism relies on active constriction or dilation of resistance vessels based on local factors like carbon dioxide levels.
*The curve shifts to the right in cases of chronic hypertension, meaning higher pressures are required to maintain flow.
*Conversely, the curve shifts to the left for infants younger than six months due to immature adaptive mechanisms.
https://t.co/SchLh029BU
🧠 Hypertonic Saline vs Mannitol in Severe Traumatic Brain Injury: Is There a Winner?
Hyperosmolar therapy remains a cornerstone of intracranial hypertension management after severe TBI, but the optimal agent is still debated.
A recent systematic review including 9 studies and 979 adult patients compared hypertonic saline (HTS) with mannitol. HTS demonstrated several potential advantages:
🔹 Faster and more sustained reduction of intracranial pressure (ICP).
🔹 Lower recurrence of intracranial hypertension episodes.
🔹 Reduced treatment failure rates in refractory ICP elevation.
🔹 More prolonged osmotic effect compared with mannitol.
However, not all studies showed superiority. Nearly half reported similar efficacy between both agents regarding ICP control and clinical outcomes.
Importantly:
✅ HTS may provide better maintenance of cerebral perfusion by expanding intravascular volume without the diuretic effects of mannitol.
✅ Mortality differences were not consistently demonstrated.
✅ Functional neurological outcomes remain uncertain.
The practical message for intensivists and neurocritical care clinicians is that both agents remain reasonable options, but current evidence increasingly favors HTS when sustained ICP control is the primary therapeutic goal.
Further large, multicenter randomized trials are still needed to define whether physiological advantages translate into meaningful improvements in long-term neurological outcomes.
#NeurocriticalCare #TBI #ICP #CriticalCare #Trauma #NeuroICU #HypertonicSaline #Mannitol #BrainInjury #IntensiveCare
Reference 📚
Expósito A, Silva AN, Capelo NM, Zamora CF, Cuji DG. Efficacy of hypertonic saline versus mannitol in adult patients with severe head trauma: systematic review. Revista Gregoriana de Ciencias de la Salud. 2026;3(1):186-202. DOI: 10.36097/rgcs.v3i1.3213.
FEVER + RASH + ARTHRITIS
One of the most important diagnostic patterns in medicine.
When these three features occur together, the differential diagnosis extends far beyond rheumatology and includes infection, systemic inflammatory disease, autoimmunity, and post-infectious syndromes.
Key diagnoses you should never miss:
• Adult-onset Still disease / Systemic JIA
• SLE
• Reactive arthritis
• Viral arthritis
• Disseminated gonococcal infection
• Behçet disease
• Infective endocarditis
• Acute rheumatic fever
Before ordering a large autoimmune panel, ask yourself:
Which diagnosis would I regret missing today?
What would be your first differential when faced with a patient presenting with fever, rash, and arthritis?
Infographic by Dr. Aravind Palraj
#Rheumatology #InternalMedicine #MedicalEducation #MedEd #FOAMed #ClinicalReasoning #DifferentialDiagnosis #AutoimmuneDisease #MedTwitter #RheumTwitter #InfectiousDiseases #MedX #MedicalStudents #Residency #Medicine @IhabFathiSulima@docakx
𝗦𝘂𝗴𝗴𝗲𝘀𝘁𝗲𝗱 𝗥𝗲𝘃𝗲𝗿𝘀𝗮𝗹 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗲𝘀 𝗼𝗳 𝗢𝗿𝗮𝗹 𝗔𝗻𝘁𝗶𝗰𝗼𝗮𝗴𝘂𝗹𝗮𝗻𝘁 𝗨𝘀𝗲 𝗳𝗼𝗿 𝗠𝗮𝗷𝗼𝗿 𝗕𝗹𝗲𝗲𝗱𝗶𝗻𝗴 𝗮𝗻𝗱 𝗯𝗲𝗳𝗼𝗿𝗲 𝗘𝗺𝗲𝗿𝗴𝗲𝗻𝗰𝘆 𝗦𝘂𝗿𝗴𝗲𝗿𝘆.
As shown in Panel A, reversal management depends on the urgency of surgery or the invasive procedure. Reversal management includes administration of oral or intravenous (IV) vitamin K with or without 4F-PCC, depending on the timing of the procedure (emergency or urgent), baseline international normalized ratio (INR) value, and presence (or absence) of active bleeding. For patients receiving direct oral anticoagulants (DOACs), the decision also depends on time to surgery. Decision making is informed by DOAC type, time since last dose, half-life, presence (or absence) of active bleeding, and renal function tests to estimate residual drug activity.
Panel B shows reversal strategies for patients presenting with major bleeding while receiving an oral anticoagulant. The reversal strategy of vitamin K antagonists includes vitamin K given intravenously or orally, combined with 4F-PCC and INR testing. Management of anticoagulant reversal of direct oral FXaIs is based on four key factors (shown as the 4Ts): type of bleeding, timing of the last dose, thrombotic risk, and need for invasive procedures in the next 48 hours that would result in the administration of UFH. These factors may facilitate the use of specific (e.g., andexanet alfa) or nonspecific (e.g., 4F-PCC) antidotes. The reversal of dabigatran is informed by three clinical variables (shown as the 3Rs) — the type of bleeding, time of the last dose of dabigatran, and preserved renal function.
Learn more in the Review Article “Antidotes for Anticoagulation Reversal” by Bianca Rocca, MD, PhD, and Hugo ten Cate, MD, PhD: https://t.co/XobqwMebfy
NEJM subscribers: Explore this article deeper with AI Companion.
Day1 at #CCR26#LOGICALtrial: conservative O₂ after cardiac arrest
#MARCHtrial: carbocisteine +/or HTS for airway secretions
#VICTORYtrial: high-dose IV vitaminC in burns
None improved outcomes; MARCH and VICTORY➡️possible harm!
✅#TeleRehabTrial: in AHRF pts, ⬆️QoL+⬇️mortality
DKA Patient. Blood sugar 650 mg/dL.
If the intern reaches for IV insulin & i would stop him first
❌ Wrong first move why?
Always assess ABCD first:
Airway
Breathing (Kussmaul respirations?)
Circulation
Disability (mental status)
Then the real priority:
IV Fluids FIRST (0.9% Normal Saline) before even starting IV insulin.
In DKA, the patient is profoundly dehydrated (often 5–8 L fluid deficit) from osmotic diuresis. The high sugar is only part of the problem.
Giving insulin immediately can be dangerous because:
➡️ Insulin drives glucose AND potassium into cells.
➡️ Serum K⁺ can crash suddenly :- fatal arrhythmias.
➡️ Rapid fall in serum osmolality can pull water into brain cells :- cerebral edema (especially in children).
The sequence is:
✅ Aggressive IV fluids
✅ Check potassium
✅ Replace K⁺ if needed
✅ Then start IV insulin infusion
DKA isn’t just a sugar high problem we need to address the dehydration + electrolyte + acid-base abnormality
But medicine is cruelly deceptive sometimes.
Pulse oximetry only tells you one thing:
➡️ What percentage of hemoglobin is carrying oxygen.
It does NOT tell you:
❌ How much hemoglobin the patient actually has
❌ Whether oxygen is reaching tissues
❌ Whether cells are even able to use that oxygen
That’s why a patient can have “perfect saturation” and still be critically hypoxic in conditions like:
• Severe anemia → no oxygen carrying capacity
• Carbon monoxide poisoning → falsely normal/high SpO₂
• Cyanide poisoning → oxygen cannot be utilized by cells
• Septic or cardiogenic shock → oxygen never reaches tissues adequately
This is the moment juniors realize:
A monitor showing “100%” does not always mean the patient is safe.
Real medicine starts when you stop treating numbers… and start understanding physiology.
❤️ Pressure-Volume Loops at the Bedside: Are We Finally Measuring What Really Matters in Cardiogenic Shock?
For decades, cardiogenic shock management has focused on cardiac output, blood pressure, filling pressures, lactate, and cardiac power.
A fascinating multicenter study published in the ASAIO Journal proposes a practical bedside method to estimate pressure-volume (PV) loop energetics using only pulmonary artery catheter and echocardiographic data, avoiding the need for invasive conductance catheters.
Why does this matter?
Traditional hemodynamic variables tell us about flow and pressure.
PV-loop analysis tells us about:
📌 Ventriculoarterial coupling (VAC)
📌 Ventricular efficiency
📌 Stroke work (SW)
📌 Potential energy (PE)
📌 Pressure-volume area (PVA)
📌 Myocardial energetic demand
These parameters may provide a much deeper understanding of whether a therapy truly unloads the failing ventricle.
Key Findings
🔹 Microaxial flow pump support in AMI-related cardiogenic shock
The most striking observation was a reduction in arterial elastance and improved ventriculoarterial coupling, accompanied by increased stroke work but decreased pressure-volume area.
This translated into an improvement in estimated ventricular efficiency from approximately 32% to 40%, suggesting genuine ventricular unloading and lower energetic expenditure.
🔹 IABP support in AMI-related shock
IABP improved ventriculoarterial coupling and reduced filling pressures but produced a more modest energetic effect compared with microaxial support.
🔹 Heart failure-related cardiogenic shock
The physiological response was far more heterogeneous. Changes in pressure-volume area and ventricular energetics were inconsistent, highlighting that device effects may depend strongly on shock etiology.
Why This Study Is Important
This work reinforces a concept increasingly discussed in advanced heart failure and shock programs:
The goal is not simply increasing cardiac output.
The goal is improving systemic perfusion while simultaneously reducing myocardial oxygen consumption and ventricular workload.
A patient can have a higher cardiac output while still operating at an unfavorable energetic state.
Pressure-volume analysis may reveal this hidden physiology.
Practical ICU Takeaway
When evaluating mechanical circulatory support, we should ask three questions:
1️⃣ Is systemic perfusion improving?
2️⃣ Is ventricular filling pressure decreasing?
3️⃣ Is ventricular energetic demand falling?
Only when all three occur simultaneously can we confidently say that true ventricular unloading has been achieved.
The future of cardiogenic shock management may be less about isolated hemodynamic variables and more about understanding the complete interaction between the ventricle and the arterial system.
Reference 📚
Ortega-Hernández JA. ASAIO Journal. 2026. DOI: 10.1097/MAT.0000000000002737.
A family member in the casualty was furious. "Doc, my father is unconscious from liver failure and you are just giving him a laxative to make him poop? He needs brain medicine!"
I had to explain that the laxative is the brain medicine.
🧵 Albumin in Critical Care: 70 Years, 700 Papers… Zero Benefit
1/
Albumin is the most studied fluid in critical care.
Decades of trials. Endless meta-analyses.
And yet – not a single clinically meaningful benefit.
Here’s why the entire theory collapses once you understand Extended Starling. 👇
Version 2 of our ShockCalcs hemodynamics simulator is live. I've refined the physiology a ton, added new meds, and also a real-time Frank Starling curve that responds to fluids + vasopressors.
Check it out (link in reply), and reply here with feedback on how to improve further!